Entero Healthcare Solutions Limited has informed the Exchange regarding 'Entero healthcare Solutions Ltd as informed the Exchange regarding 'Submission of Business Responsibility & Sustainability Report for FY 2024-25'.
ENTERO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Entero Healthcare Solutions has filed its Business Responsibility and Sustainability Report (BRSR) for FY 2024-25 with the stock exchanges, as required under SEBI's Listing Regulations. The company is a B2B pharmaceutical and healthcare products distributor with 100% of revenue from this single business line, operating 102 warehouses across 20 states with 47 subsidiaries. Standalone turnover for the year stood at around Rs 408.67 crore with a net worth of about Rs 1,650.38 crore. Total employee count is 4,258 (73.57% male, 26.42% female), and the company serves 98,900+ customers including retail pharmacies, hospitals, and clinics. No fines, penalties, or safety incidents were reported during the year, and material ESG risks identified include GHG emissions and fleet fuel management, while employee welfare and business ethics were flagged as opportunities.
This is a routine annual regulatory disclosure and is unlikely to cause any immediate movement in the stock price. It gives investors a useful view of the company's ESG practices, workforce composition, and supplier/customer concentration, with no negative flags raised this year.